Avantor, Inc. $AVTR Stock Position Increased by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. increased its position in Avantor, Inc. (NYSE:AVTR) by 17.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 889,336 shares of the company’s stock after buying an additional 132,280 shares during the quarter. Envestnet Asset Management Inc. owned about 0.13% of Avantor worth $11,099,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of AVTR. Greenhaven Associates Inc. acquired a new stake in Avantor in the 3rd quarter valued at about $228,528,000. Dodge & Cox boosted its holdings in Avantor by 17.1% during the second quarter. Dodge & Cox now owns 117,433,484 shares of the company’s stock worth $1,580,655,000 after buying an additional 17,170,761 shares in the last quarter. Norges Bank acquired a new position in Avantor in the second quarter worth approximately $108,167,000. Engine Capital Management LP bought a new position in shares of Avantor in the second quarter valued at $74,088,000. Finally, Clarkston Capital Partners LLC lifted its position in shares of Avantor by 45.8% during the 2nd quarter. Clarkston Capital Partners LLC now owns 13,982,090 shares of the company’s stock valued at $188,199,000 after acquiring an additional 4,390,140 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Insider Activity at Avantor

In related news, Director Gregory L. Summe purchased 100,000 shares of the stock in a transaction on Thursday, February 12th. The shares were bought at an average price of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the acquisition, the director directly owned 400,000 shares in the company, valued at approximately $3,760,000. This trade represents a 33.33% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Sanjeev K. Mehra bought 350,000 shares of the business’s stock in a transaction on Friday, December 5th. The shares were purchased at an average cost of $11.09 per share, with a total value of $3,881,500.00. Following the transaction, the director owned 350,000 shares in the company, valued at approximately $3,881,500. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 1.20% of the stock is currently owned by insiders.

Avantor Stock Performance

AVTR stock opened at $9.05 on Wednesday. The firm has a 50 day moving average of $11.32 and a two-hundred day moving average of $12.15. Avantor, Inc. has a 12 month low of $8.90 and a 12 month high of $18.02. The company has a market capitalization of $6.17 billion, a price-to-earnings ratio of -11.60, a P/E/G ratio of 3.62 and a beta of 0.94. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.01. The business had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. Avantor’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.27 EPS. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, equities analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on AVTR shares. TD Cowen reaffirmed a “hold” rating on shares of Avantor in a research report on Thursday, February 12th. Zacks Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research report on Monday, December 29th. Evercore set a $10.00 price objective on shares of Avantor in a research note on Wednesday, February 11th. Robert W. Baird set a $11.00 target price on shares of Avantor in a research note on Thursday, February 12th. Finally, Jefferies Financial Group reiterated an “underperform” rating and set a $8.00 price target on shares of Avantor in a report on Thursday, February 12th. Three analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $11.83.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.